Skip to content
#

autoimmune

Here are 29 public repositories matching this topic...

Red RidgeBio — independent third-party profile of a public API surface, by API Evangelist. RedRidge Bio is a clinical-stage biotechnology company that identifies and develops biparatopic antibodies, an antibody class engineered to bind two distinct sites (epitopes) on a single target protein for greater potency and selectivity.

  • Updated Sep 16, 2026

WellTheory — independent third-party profile of a public API surface, by API Evangelist. WellTheory is a virtual autoimmune care platform that provides whole-person support for people living with autoimmune and inflammatory conditions, pairing members with a dedicated care team for nutrition, lifestyle, and clinical guidance across more than 100 co

  • Updated Sep 16, 2026

LongBio Pharma — independent third-party profile of a public API surface, by API Evangelist. LongBio Pharma (Suzhou/Shanghai, founded 2020) is a Chinese clinical-stage biopharmaceutical company focused on the in-house discovery and development of innovative antibody and fusion-protein therapeutics for allergic, autoimmune, and complement-mediated d

  • Updated Sep 16, 2026

Georgiamune — independent third-party profile of a public API surface, by API Evangelist. Georgiamune Inc. is a Gaithersburg, Maryland based biopharmaceutical company developing first-in-class immunotherapies that reprogram immune signaling pathways to rebalance the immune system and restore health across cancer and autoimmune diseases.

  • Updated Sep 16, 2026

Oblenio Bio — independent third-party profile of a public API surface, by API Evangelist. Oblenio Bio is a clinical-stage biotechnology company developing tri-specific antibody immunotherapies for refractory autoimmune diseases. Its lead candidate, LBL-051, is a tri-specific T-cell engager targeting BCMA, CD19, and CD3 to deplete B-cells and pursue

  • Updated Sep 16, 2026

Zenasbio — independent third-party profile of a public API surface, by API Evangelist. Zenas BioPharma is a global clinical-stage biopharmaceutical company focused on developing and delivering transformative treatments for patients with autoimmune and rare diseases. Its lead candidates are obexelimab, a bifunctional monoclonal antibody that inhibit

  • Updated Sep 16, 2026

Add this topic to your repo

To associate your repository with the autoimmune topic, visit your repo's landing page and select "manage topics."

Learn more